Steven C. Quay's most recent trade in Atossa Therapeutics Inc was a trade of 11,239 Common Stock done at an average price of $0.9 . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atossa Therapeutics Inc | Steven C. Quay | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.88 per share. | 21 May 2025 | 11,239 | 13,898 (0%) | 0% | 0.9 | 9,887 | Common Stock |
| Atossa Therapeutics Inc | Steven C. Quay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 1,366,062 | 1,366,062 | - | - | Stock Option (right to buy) | |
| Atossa Therapeutics Inc | Steven C. Quay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 1,795,100 | 1,795,100 | - | - | Stock Option (right to buy) | |
| Atossa Therapeutics Inc | Steven C. Quay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 1,873,100 | 1,873,100 | - | - | Stock Option (right to buy) | |
| Atossa Therapeutics Inc | Steven C. Quay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 1,900,000 | 1,900,000 | - | - | Stock Option (right to buy) | |
| Atossa Therapeutics Inc | Steven C. Quay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 1,900,000 | 1,900,000 | - | - | Stock Option (right to buy) | |
| Atossa Therapeutics Inc | Steven C. Quay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 1,900,000 | 1,900,000 | - | - | Stock Option (right to buy) |